NorthWest Biotherapeutics Inc (NWBO)

[iwasadiver]

A total of 2 are in the “clinic” in a Phase I study. PACT is not yet remotely relevant other than a speculative player among many other T Cell therapeutics. To compare to DCVax-L or imply it’s a much better “platform” at this stage, especially given the inherent problems with T Cell therapies so far. You don’t need to keep doing this, PACT could be a great investment, just quit trying to make everything in your microcosmic atmosphere to be better already when there’s barely any evidence.